StockData
Avalyn Pharma Inc. logo

Avalyn Pharma Inc. (AVLN) bonds

AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.92−1.84 (-6.18%)

Close on Nov 17, 2026Market cap $1.24BP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$14.80M
Long-term debt
Net debt
-$249.40M
After $264.20M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in Avalyn Pharma's 10-Q for the period ended Jun 30, 2026

IssueMaturesCarrying value
Loan And Security AgreementJun 30, 2030$15.00M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?